Diabetic Kidney Disease

被引:148
|
作者
Bonner, Ryan [1 ,2 ]
Albajrami, Oltjon [1 ,2 ]
Hudspeth, James [1 ,2 ]
Upadhyay, Ashish [1 ,2 ]
机构
[1] Boston Med Ctr, Dept Med, Sect Nephrol, 800 Harrison Ave,G009, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, 800 Harrison Ave,G009, Boston, MA 02118 USA
来源
PRIMARY CARE | 2020年 / 47卷 / 04期
关键词
Diabetic kidney disease; Diabetic nephropathy; Chronic kidney disease; Albuminuria; RENIN-ANGIOTENSIN SYSTEM; CARDIOVASCULAR OUTCOMES; ACE-INHIBITION; DOUBLE-BLIND; THERAPEUTIC TARGET; GLUCOSE CONTROL; RENAL OUTCOMES; DUAL BLOCKADE; TYPE-2; NEPHROPATHY;
D O I
10.1016/j.pop.2020.08.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Diabetic kidney disease (DKD) is the most common cause of chronic kidney disease in the United States. Approximately 30% to 40% of individuals with diabetes mellitus develop DKD, and the presence of DKD significantly elevates the risk for morbidity and mortality. Understanding of DKD has grown in recent years. This review describes the pathogenesis of DKD and expands on evidence-based strategies for DKD management, integrating traditional approaches for hyperglycemia, hypertension, and albuminuria management with emerging therapeutic options. Given the public health burden of DKD, it is essential to prioritize prevention, recognition, and management of DKD in the primary care setting.
引用
收藏
页码:645 / 659
页数:15
相关论文
共 50 条
  • [41] Diagnosis 101: diabetic kidney disease
    Lerma, Edgar, V
    CLINICAL KIDNEY JOURNAL, 2022, 15 (10) : 1797 - 1799
  • [42] Anemia in patients of diabetic kidney disease
    Tsai, Shang-Feng
    Tarng, Der-Cherng
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (10) : 752 - 755
  • [43] Incretins in the Therapy of Diabetic Kidney Disease
    Przezak, Agnieszka
    Bielka, Weronika
    Pawlik, Andrzej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [44] Diabetic kidney disease with and without albuminuria
    MacIsaac, Richard J.
    Jerums, George
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (03) : 246 - 257
  • [45] Precision medicine approaches for diabetic kidney disease: opportunities and challenges
    Tye, Sok Cin
    Denig, Petra
    Heerspink, Hiddo J. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 3 - 9
  • [46] A new perspective on proteinuria and drug therapy for diabetic kidney disease
    Zhang, Ruimin
    Wang, Qian
    Li, Yaqing
    Li, Qihu
    Zhou, Xuefeng
    Chen, Xiangmei
    Dong, Zheyi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [47] Slowing the Progression of Diabetic Kidney Disease
    Blazek, Olivia
    Bakris, George L. L.
    CELLS, 2023, 12 (15)
  • [48] Oxidative Stress and Diabetic Kidney Disease
    Stanton, Robert C.
    CURRENT DIABETES REPORTS, 2011, 11 (04) : 330 - 336
  • [49] Therapeutic management of diabetic kidney disease
    Koya, Daisuke
    Araki, Shin-ichi
    Haneda, Masakazu
    JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (04) : 248 - 254
  • [50] Use of renin-angiotensin-aldosterone system blockade in controversial chronic kidney disease populations
    Garcia-Prieto, Ana Maria
    Verdalles, Ursula
    Goicoechea, Marian
    MEDICINA CLINICA, 2021, 156 (11): : 561 - 567